Amgen USA Inc.Usage: REPATHA is indicated to reduce the risk of major adverse cardiovascular events in adults with established cardiovascular disease, and to lower LDL-C levels in adults and pediatric patients (10 years and older) with primary hyperlipidemia, heterozygous, or homozygous familial hypercholesterolemia.